Therapeutic Drug Monitoring

Therapeutical drug monitoring is defined as the clinical laboratory measurement of a chemical parameter that will directly influence drug prescribing procedures after appropriate medical interpretation. TDM refers to maintaining blood drug or plasma concentrations within a targeted therapeutic range or window for the individualization of drug dosage. Drug Monitoring begins after the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and patient characteristics like age, organ function, weight and concomitant drug therapy.

The global therapeutic drug monitoring market was valued USD 1.77 billion in 2015 and it will be expected to reach over USD 3.37 billion by 2024 and shows significant growth in CAGR over the last few years.

  •  Therapeutic range
  • Biomonitoring
  • Blood glucose monitoring

Related Conference of Therapeutic Drug Monitoring

January 22-23, 2026

26th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
February 25-26, 2026

16th International Conference on Chemistry Meeting

Paris, France
February 26-27, 2026

29th World Congress on Materials Chemistry

Paris, France
June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain

Therapeutic Drug Monitoring Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in